View More View Less
  • 1 Assiut University, Assiut 71526, Egypt
Restricted access

Cross Mark

The combination of xanthine oxidase inhibitor febuxostat (FBX) with acetaminophen (ACE) is widely used in the treatment of gout. A rapid, simple, selective, and precise densitometric method was developed and validated for the simultaneous estimation of FBX–ACE mixture in a synthetic binary mixture and in their pharmaceutical dosage forms. The method employed thin-layer chromatography (TLC) aluminum plates precoated with silica gel G 60 F254 as the stationary phase using chloroform‒methanol‒cyclohexane‒acetic acid 96% (7:1:1:0.1, v/v) as the mobile phase. The optimized mobile phase selected for development gave compact bands (RF values were 0.65 and 0.46 for FBX and ACE, respectively). Spectrodensitometric scanning integration was performed using dual-wavelength detection at 320 and 250 nm for FBX and ACE, respectively. The linear regression data for the calibration plots showed excellent linear relationship (r = 0.9997 and 0.9992 for FBX and ACE, respectively). The method was validated for precision, accuracy, robustness, and recovery. The limits of detection and quantification were calculated. The statistical analysis proved that the method is reproducible and selective for the estimation of this binary mixture.

  • [1]

    K.H. Yu , Recent Pat. Inflamm. Allergy Drug Discov. 1 (2007) 6975.

  • [2]

    S.C. Sweetman , Martindale: The Complete Drug Reference, 38th edn., Pharmaceutical Press, London, 2016.

  • [3]

    J.A. Bernal , N. Quilis, M. Andres, F. Sivera, E. Pascual, Ther. Adv. Chronic. Dis. 7 (2016) 135144.

  • [4]

    S.E. Sattui , A.L. Gaffo, Ther. Adv. Musculoskelet. Dis. 8 (2016) 145159.

  • [5]

    S.P. Chinchilla , I. Urionaguena, F. Perez-Ruiz, Expert Rev. Clin. Pharmacol. 9 (2016) 66573.

  • [6]

    http://www.healthtalk.org/peoples-experiences/bones-joints/gout/treating-pain-and-inflammation-attacks; accessed in December 2016.

  • [7]

    J.M. Derasari , V.B. Patel, Asian J. Chem.; Ghaziabad 29 (2017) 6975.

  • [8]

    O. Lukram , S. Parmar, A. Hande, Drug Test. Anal. 5 (2013) 492499.

  • [9]

    N. Pal , A.S. Rao, P. Ravikumar, Int. J. Pharm. Pharm. Sci. 8 (2016) 61.

  • [10]

    U.P. Panigrahy , A.S.K. Reddy, Int. J. Pharm. Sci. Res. 6 (2015) 798807.

  • [11]

    D. Tandel , P. Shah, K. Patel, V. Thakkar, K. Patel, T. Gandhi, J. Chromatogr. Sci. 10 (2016) 18271833.

  • [12]

    Y. Wu , Z. Mao, Y. Liu, X. Wang, X. Di, J. Pharm. Biomed. Anal. 114 (2015) 216221.

  • [13]

    M.A.A. Ragab , J. Chromatogr. Sci. 51 (2013) 383390.

  • [14]

    R-y. Gao , F-r Wei, L-y Nie, L. Wu, J. Chen, M-q. Shan, Qilu. Pharm. Affairs 1 (2011); retrieved from http://en.cnki.com.cn/Article_en/CJFDTOTAL-SDYG201101017.htm.

    • Search Google Scholar
    • Export Citation
  • [15]

    J. Zhang , W-y. Zhou, Q-h. Wu, Strait Pharm. J. 2 (2011); retrieved from http://en.cnki.com.cn/Article_en/CJFDTotal-HAIX201102026.htm.

  • [16]

    S-l. Zhu , Y-r. Li, X-g. Song, China Pharm. 25 (2012); retrieved from http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYA201225028.htm.

  • [17]

    S.M. Song , P. Marriott, A. Kotsos, O.H. Drummer, P. Wynne, Forensic Sci. Int. 143 (2004) 87101.

  • [18]

    F.A. El Yazbi , E.M. Hassan, E.F. Khamis, M.A.A. Ragab, M.M.A. Hamdy, J. Chromatogr. Sci. 54 (2016) 819828.

  • [19]

    F.A. El-Yazb , O.A. Amin, E.I. El-Kimary, E.F. Khamis, S.E. Younis, J. Chromatogr. Sci. 54 (2016) 11461152.

  • [20]

    M. Gulzar Khan , A. Shirkhedkar, Curr. Pharm. Anal. 12 (2016) 266273.

  • [21]

    A. Halka-Grysinska , P. Slazak, G. Zareba, W. Markowski, A. Klimek-Turek, T.H. Dzido, Anal. Methods 4 (2012) 973982.

  • [22]

    N. Dubey , D.K. Jain, S. Jadhawani, J. Planar Chromatogr. 25 (2012) 162167.

  • [23]

    E.A. Abdelaleem , N.S. Abdelwahab, J. Chromatogr. Sci. 51 (2013) 187191.

  • [24]

    M.E. El-Kommos , S.M. El-Gizawy, N.N. Atia, N.M. Hosny, Biomed. Chromatogr. 28 (2014) 391400.

  • [25]

    J.M. Derasari , V.B. Patel, Asian J. Res. Chem. 6 (2013) 968972.

  • [26]

    G. Kumaraswamy , J.M.R. Kumar, J.V.L.N. Sheshagirirao, Int. J. ChemTech Res. 4 (2012) 847850.

  • [27]

    M. Sheth , S. Joshi, M. Patel, Int. J. Pharm. Sci. Res. 3 (2012) 16211624.

  • [28]

    P. Bagga , M. Salman, H.H. Siddiqui, M. Abdul, T.M. Ansari, Int. J. Pharm. Sci. Res. 2 (2011) 26552659.

  • [29]

    M.S. Sudhir , P. Madan Mohan, R. Venkata Nadh, Orient J. Chem. 29 (2013) 235240.

  • [30]

    M. Shalash , A. Salhin, B. Saad, I.A. Rahman, J. Liq. Chromatogr. Relat. Technol. 36 (2012) 155166.

  • [31]

    N.R. Modi , S.D. Patel, A.N. Patel, R.R. Parmar, V.N. Shah, D.A. Shah, Inventi Rapid: Pharm. Anal. Qual. Assur. (2013); retreived from http://inventi.in/journal/article/rapid/4/10541/pharm-analysis-quality-assurance/pi.

    • Search Google Scholar
    • Export Citation
  • [32]

    M.A. Omar , A-M.I. Mohamed, S.M. Derayea, M.A. Hammad, A.A. Mohamed, RSC Adv. 6 (2016) 7343273439.

  • [33]

    A.B. Moreira , I.L.T. Dias, G.O. Neto, E.A.G. Zagatto, L.T. Kubota, Anal. Lett. 39 (2006) 349360.

  • [34]

    E.J. Llorent-Martinez , D. Satinsky, P. Solich, P. Ortega-Barrales, A. Molina-Diaz, J. Pharm. Biomed. Anal. 45 (2007) 318321.

  • [35]

    P. Abu-rabie , P. Denni, N. Spooner, J. Brynjol, P. Galluzzo, G. Sanders, Anal. Chem. 83 (2011) 87798786.

  • [36]

    E.L. Harry , J.C. Reynolds, A.W.T. Bristow, I.D. Wilson, C.S. Creaser, Rapid Commun. Mass Spectrom. 23 (2009) 25972604.

  • [37]

    R. Bhushan , D. Gupta, A. Mukherjee, Biomed. Chromatogr. 21 (2007) 12841290.

  • [38]

    ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology, Q2 (R1) Geneva, 2005; http://www.ich.org.

    • Search Google Scholar
    • Export Citation
  • [39]

    B. Renger , Z. Végh, K. Ferenczi-Fodor, J. Chromatogr. A 1218 (2011) 27122721.

All Time Past Year Past 30 Days
Abstract Views 54 54 1
Full Text Views 25 9 0
PDF Downloads 18 8 0